Sera Prognostics, Inc. (SERA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.07
+3.25%
Mkt Cap $72.62M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+142.1%
Consensus $5.00 vs current $2.07